Condition

Radiation Induced Oral Mucositis (3)

Head and Neck Cancer (1)

Nasopharyngeal Carcinoma (1)

Pain (1)

Overall Status

Unknown status (2)

Completed (1)

Sign in for free

Phase

n/a (1)

phase 2 (1)

phase 4 (1)

Sponsor

Fujian Cancer Hospital (1)

Galera Therapeutics, Inc. (1)

Jiarong Chen, MD (1)

Collaborator

Intervention

cisplatin (1)

fentanyl (1)

high dose gc4419: 90mg/day (1)

intensity-modulated radiation therapy (1)

lappaconitine adhesive patch (1)

low dose gc4419: 30mg/day (1)

morphine (1)

placebo (1)

standard care (1)

Study Documents

Intervention Type

drug (3)

radiation (1)

Funder Type

Other (2)

Industry (1)

Study Type

Interventional (3)

radiation induced oral mucositis

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Radiation Induced Oral Mucositis Trial in Canada, Puerto Rico, United States (Low Dose GC4419: 30mg/day, High Dose GC4419:

Completed

Has Results

Radiation Induced Oral Mucositis

Low Dose GC4419: 30mg/day
+4 more

Phoenix, Arizona
+63 more

Aug 23, 2021

Pain, Nasopharyngeal Carcinoma, Head Neck Cancer Trial (Fentanyl, Morphine)

Unknown status

Pain
+3 more

(no location specified)

Jul 28, 2020

Radiation Induced Oral Mucositis Trial in Fuzhou (Lappaconitine Adhesive Patch, standard care)

Unknown status

Radiation Induced Oral Mucositis

Lappaconitine Adhesive Patch
standard care

Fuzhou, Fujian, China

Fujian Cancer Hospital Radiation Oncology Department

May 11, 2018